Head-to-head · WeighScore
GoodRx vs Potere Health MD
The verdict
Potere Health MD takes it — 72.5/100 to 69.6/100.
Potere Health MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Potere Health MD is a Utah-based, physician-led weight loss clinic offering semaglutide and tirzepatide in both FDA-approved and compounded forms via telehealth and in-person visits.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | GoodRx | Potere Health MD |
|---|---|---|
| WeighScore | 69.6/100 | 72.5/100 |
| Grade | C | C |
| Scorecard rank | #116 | #77 |
| Semaglutide | Not disclosed | $80/mo (starting dose, compounded) |
| Tirzepatide | $299/mo (brand Zepbound) | $135/mo (starting dose, compounded) |
| Coverage | All 50 states | 1 state |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #116 · C
Strengths
- $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
- $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
- Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
- No membership fee — bring your own prescription and present the discount card at the pharmacy counter
- Brand-name FDA-approved medication, not compounded
Where it loses points
- Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
- Self-pay only — does not apply toward insurance benefits or deductibles
- Headline price applies to the lowest Foundayo dose; higher doses may cost more
- No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
- Pricing can change as Lilly's manufacturer coupon program evolves
Graded #77 · C
Strengths
- Low starting pricing (about $80-$135/month) with no subscription lock-in
- Physician-led by a named MD, not automated messaging
- Third-party COA and LegitScript-certified pharmacy
- Both telehealth and in-person Utah visits with fast scheduling
Where it loses points
- Available in Utah only — a St George clinic offering telehealth within the state, not a national service
- The per-vial price is fixed, so the monthly cost rises steeply with the dose: the provider's own table runs about $20/mo at 0.25 mg, $80/mo at 1.0 mg and about $199/mo at 2.5 mg
- Medication is bought per vial up front rather than on a subscription, so there is no monthly rate to compare directly against a subscription programme
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.